These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23622837)

  • 21. Bacterial contamination of blood products in Africa.
    Ahmad Y; Heroes AS; Hume HA; Farouk M; Owusu-Ofori A; Gehrie EA; Goel R; Ness PM; Tobian AAR; Bloch EM
    Transfusion; 2021 Mar; 61(3):767-780. PubMed ID: 33469916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current debate on pathogen inactivation of platelet concentrates--to use or not to use?
    Hervig T; Seghatchian J; Apelseth TO
    Transfus Apher Sci; 2010 Dec; 43(3):411-414. PubMed ID: 21075686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial contamination of blood components.
    Brecher ME; Hay SN
    Clin Microbiol Rev; 2005 Jan; 18(1):195-204. PubMed ID: 15653826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Component pathogen inactivation: a critical review.
    Prowse CV
    Vox Sang; 2013 Apr; 104(3):183-99. PubMed ID: 23134556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial contamination of platelets for transfusion: strategies for prevention.
    Levy JH; Neal MD; Herman JH
    Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS; Hervig T; Seghatchian J; Reikvam H
    Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogen inactivation of platelet concentrates and fresh frozen plasma.
    Jackson JE
    Br J Biomed Sci; 2003; 60(4):227-32. PubMed ID: 14725341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacterial contamination of platelet concentrates].
    Araújo F; Alves V; Oliveira G; Fonseca C; Araújo AR
    Sangre (Barc); 1996 Dec; 41(6):483-4. PubMed ID: 9148429
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates.
    Riedel S; Siwek G; Beekmann SE; Richter SS; Raife T; Doern GV
    J Clin Microbiol; 2006 Jun; 44(6):2262-4. PubMed ID: 16757635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current position on methodological, clinical and regulatory aspects.
    Irsch J; Seghatchian J
    Transfus Apher Sci; 2015 Apr; 52(2):240-4. PubMed ID: 25824703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfusion-transmitted bacterial infection: residual risk and perspectives of prevention].
    Morel P; Deschaseaux M; Bertrand X; Naegelen C; Talon D
    Transfus Clin Biol; 2003 Jun; 10(3):192-200. PubMed ID: 12798856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial contamination of blood products: factors, options, and insights.
    Depcik-Smith ND; Hay SN; Brecher ME
    J Clin Apher; 2001; 16(4):192-201. PubMed ID: 11835416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
    Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
    Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross.
    Benjamin RJ; Kline L; Dy BA; Kennedy J; Pisciotto P; Sapatnekar S; Mercado R; Eder AF
    Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
    Di Minno G; Navarro D; Perno CF; Canaro M; Gürtler L; Ironside JW; Eichler H; Tiede A
    Ann Hematol; 2017 Aug; 96(8):1253-1270. PubMed ID: 28624906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
    Delbosc A; Lafeuillade B; Petermann R; Eb F; Ounnoughene N
    Transfus Clin Biol; 2011 Feb; 18(1):26-35. PubMed ID: 21310643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of bacterial transmission and transfusion reactions by blood components.
    Walther-Wenke G
    Clin Chem Lab Med; 2008; 46(7):919-25. PubMed ID: 18605950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving platelet safety: bacterial contamination of platelets.
    Brecher ME; Hay SN
    Curr Hematol Rep; 2004 Mar; 3(2):121-7. PubMed ID: 14965488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.